Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cationic surfactant-induced membrane disruption is a mechanism of cell membrane damage whereby surfactants with positive charges interact with negatively charged lipid components of cellular (often bacterial) membranes. The disruption occurs via electrostatic and hydrophobic interactions: the polar (cationic) head groups bind to negatively charged lipid head groups, and the hydrophobic alkyl chains embed into the lipid bilayer. This process alters membrane structure, increases permeability, and can ultimately cause cell lysis. This mechanism is widely exploited in disinfection, antimicrobial therapy, and design of nanocarriers for drug delivery, but also poses risks of cytotoxicity and environmental harm[1][2][5][6][7][8][9].
Electrostatic attraction of cationic surfactant to negatively charged lipid head groups. Integration of surfactant hydrophobic tails into the membrane bilayer. Disruption of membrane structure, leading to increased permeability, deformation, rupture, and leakage of cytoplasmic contents.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cationic surfactant-induced membrane disruption.